Delivery Order SPE2DR25D1106-SPE2DR26FJB6B
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,173.74 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on April 24, 2025, with an ultimate completion date of April 25, 2025. This firm fixed-price, non-set-aside contract was performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,139.70 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This non-set-aside, competitively awarded contract carries a firm fixed price and an ultimate completion date of December 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. The delivery order operates as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,937.88 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The award was issued on November 13, 2025, with an ultimate completion date of November 14, 2025, and does not utilize a set-aside designation. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued against AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,862.40 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract type. The award, issued on July 9, 2025, with an ultimate completion date of July 10, 2025, represents a non-set-aside competitive procurement. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,846.52 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count). This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $59,559.83 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitive, firm fixed-price delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,082.81 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,306.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order executed under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,519.86 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This non-competitive, firm fixed-price delivery order was awarded on November 7, 2025, with an ultimate completion date of November 10, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency has awarded a delivery order valued at $106,058.99 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This non-set-aside contract employs firm fixed pricing and was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB6BDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $117,002.57 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a firm fixed price contract structure. The award, issued on December 1, 2025, is scheduled for completion by December 2, 2025, and represents a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. As a child contract under this larger vehicle, the Eliquis delivery order reflects the company's ongoing role as a critical vendor for the Defense Health Agency and other federal healthcare systems, supplying both brand-name and generic medications across multiple therapeutic domains to support military personnel and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $117.0k | 11/30/25 |